Enzyre closes Series A financing round of EUR 12M to advance pioneering diagnostic technology platform for hemophilia patients

DealMatrix gives you market-realistic EV/Sales and EV/EBITDA multiples for private companies, filtered by sector, stage and region, built on 20 years of data and IPEV-2025-compliant.